Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathway.

@article{Goldfine2008ModulatingLC,
  title={Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathway.},
  author={Allison B. Goldfine},
  journal={Current opinion in cardiology},
  year={2008},
  volume={23 5},
  pages={502-11}
}
PURPOSE OF REVIEW Individuals with type 2 diabetes mellitus (T2DM) have a number of potentially modifiable risk factors, including dyslipidemia, hypertension, and hyperglycemia, that contribute to coronary artery disease risk. Elevated low-density lipoprotein cholesterol (LDL-C) is a major contributor to coronary artery disease, and clinical trials have demonstrated significant macrovascular benefits associated with lowering LDL-C in individuals with T2DM, even in those with only a modest LDL-C… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats.

The Journal of pharmacology and experimental therapeutics • 2010
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…